These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

339 related items for PubMed ID: 15161657

  • 21. Nucleophosmin-anaplastic lymphoma kinase (NPM-ALK), a novel Hsp90-client tyrosine kinase: down-regulation of NPM-ALK expression and tyrosine phosphorylation in ALK(+) CD30(+) lymphoma cells by the Hsp90 antagonist 17-allylamino,17-demethoxygeldanamycin.
    Bonvini P, Gastaldi T, Falini B, Rosolen A.
    Cancer Res; 2002 Mar 01; 62(5):1559-66. PubMed ID: 11888936
    [Abstract] [Full Text] [Related]

  • 22. Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target.
    Chiarle R, Simmons WJ, Cai H, Dhall G, Zamo A, Raz R, Karras JG, Levy DE, Inghirami G.
    Nat Med; 2005 Jun 01; 11(6):623-9. PubMed ID: 15895073
    [Abstract] [Full Text] [Related]

  • 23. Inhibition of JAK3 induces apoptosis and decreases anaplastic lymphoma kinase activity in anaplastic large cell lymphoma.
    Amin HM, Medeiros LJ, Ma Y, Feretzaki M, Das P, Leventaki V, Rassidakis GZ, O'Connor SL, McDonnell TJ, Lai R.
    Oncogene; 2003 Aug 21; 22(35):5399-407. PubMed ID: 12934099
    [Abstract] [Full Text] [Related]

  • 24. Global proteome profiling of NPM/ALK-positive anaplastic large cell lymphoma.
    Sjostrom C, Seiler C, Crockett DK, Tripp SR, Elenitoba Johnson KS, Lim MS.
    Exp Hematol; 2007 Aug 21; 35(8):1240-8. PubMed ID: 17560012
    [Abstract] [Full Text] [Related]

  • 25. High expression of calcium-binding proteins, S100A10, S100A11 and CALM2 in anaplastic large cell lymphoma.
    Rust R, Visser L, van der Leij J, Harms G, Blokzijl T, Deloulme JC, van der Vlies P, Kamps W, Kok K, Lim M, Poppema S, van den Berg A.
    Br J Haematol; 2005 Dec 21; 131(5):596-608. PubMed ID: 16351635
    [Abstract] [Full Text] [Related]

  • 26. The expression and oncogenic effects of the embryonic stem cell marker SALL4 in ALK-positive anaplastic large cell lymphoma.
    Wang P, Zhang JD, Wu F, Ye X, Sharon D, Hitt M, McMullen TP, Hegazy SA, Gelebart P, Yang J, Ma Y, Lai R.
    Cell Signal; 2012 Oct 21; 24(10):1955-63. PubMed ID: 22743134
    [Abstract] [Full Text] [Related]

  • 27. Differential gene expression in anaplastic lymphoma kinase-positive and anaplastic lymphoma kinase-negative anaplastic large cell lymphomas.
    Thompson MA, Stumph J, Henrickson SE, Rosenwald A, Wang Q, Olson S, Brandt SJ, Roberts J, Zhang X, Shyr Y, Kinney MC.
    Hum Pathol; 2005 May 21; 36(5):494-504. PubMed ID: 15948116
    [Abstract] [Full Text] [Related]

  • 28. Role of signal transducer and activator of transcription 5 in nucleophosmin/ anaplastic lymphoma kinase-mediated malignant transformation of lymphoid cells.
    Nieborowska-Skorska M, Slupianek A, Xue L, Zhang Q, Raghunath PN, Hoser G, Wasik MA, Morris SW, Skorski T.
    Cancer Res; 2001 Sep 01; 61(17):6517-23. PubMed ID: 11522649
    [Abstract] [Full Text] [Related]

  • 29. Loss of SHP1 enhances JAK3/STAT3 signaling and decreases proteosome degradation of JAK3 and NPM-ALK in ALK+ anaplastic large-cell lymphoma.
    Han Y, Amin HM, Franko B, Frantz C, Shi X, Lai R.
    Blood; 2006 Oct 15; 108(8):2796-803. PubMed ID: 16825495
    [Abstract] [Full Text] [Related]

  • 30. Serpin A1 is overexpressed in ALK+ anaplastic large cell lymphoma and its expression correlates with extranodal dissemination.
    Duplantier MM, Lamant L, Sabourdy F, de Reynies A, Delsol G, Espinos E.
    Leukemia; 2006 Oct 15; 20(10):1848-54. PubMed ID: 16900211
    [Abstract] [Full Text] [Related]

  • 31. Multilevel dysregulation of STAT3 activation in anaplastic lymphoma kinase-positive T/null-cell lymphoma.
    Zhang Q, Raghunath PN, Xue L, Majewski M, Carpentieri DF, Odum N, Morris S, Skorski T, Wasik MA.
    J Immunol; 2002 Jan 01; 168(1):466-74. PubMed ID: 11751994
    [Abstract] [Full Text] [Related]

  • 32. Expression of STAT3 and its phosphorylated forms in mantle cell lymphoma cell lines and tumours.
    Lai R, Rassidakis GZ, Medeiros LJ, Leventaki V, Keating M, McDonnell TJ.
    J Pathol; 2003 Jan 01; 199(1):84-9. PubMed ID: 12474230
    [Abstract] [Full Text] [Related]

  • 33. JunB induced by constitutive CD30-extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase signaling activates the CD30 promoter in anaplastic large cell lymphoma and reed-sternberg cells of Hodgkin lymphoma.
    Watanabe M, Sasaki M, Itoh K, Higashihara M, Umezawa K, Kadin ME, Abraham LJ, Watanabe T, Horie R.
    Cancer Res; 2005 Sep 01; 65(17):7628-34. PubMed ID: 16140928
    [Abstract] [Full Text] [Related]

  • 34. HuR-mediated control of C/EBPbeta mRNA stability and translation in ALK-positive anaplastic large cell lymphomas.
    Bergalet J, Fawal M, Lopez C, Desjobert C, Lamant L, Delsol G, Morello D, Espinos E.
    Mol Cancer Res; 2011 Apr 01; 9(4):485-96. PubMed ID: 21343335
    [Abstract] [Full Text] [Related]

  • 35. Signal transducers and activators of transcription-3 up-regulates tissue inhibitor of metalloproteinase-1 expression and decreases invasiveness of breast cancer.
    Dien J, Amin HM, Chiu N, Wong W, Frantz C, Chiu B, Mackey JR, Lai R.
    Am J Pathol; 2006 Aug 01; 169(2):633-42. PubMed ID: 16877361
    [Abstract] [Full Text] [Related]

  • 36. A new variant anaplastic lymphoma kinase (ALK)-fusion protein (ATIC-ALK) in a case of ALK-positive anaplastic large cell lymphoma.
    Trinei M, Lanfrancone L, Campo E, Pulford K, Mason DY, Pelicci PG, Falini B.
    Cancer Res; 2000 Feb 15; 60(4):793-8. PubMed ID: 10706082
    [Abstract] [Full Text] [Related]

  • 37. Anaplastic lymphoma kinase (ALK)-induced malignancies: novel mechanisms of cell transformation and potential therapeutic approaches.
    Wasik MA, Zhang Q, Marzec M, Kasprzycka M, Wang HY, Liu X.
    Semin Oncol; 2009 Apr 15; 36(2 Suppl 1):S27-35. PubMed ID: 19393833
    [Abstract] [Full Text] [Related]

  • 38. Activation of Rac1 and the exchange factor Vav3 are involved in NPM-ALK signaling in anaplastic large cell lymphomas.
    Colomba A, Courilleau D, Ramel D, Billadeau DD, Espinos E, Delsol G, Payrastre B, Gaits-Iacovoni F.
    Oncogene; 2008 Apr 24; 27(19):2728-36. PubMed ID: 17998938
    [Abstract] [Full Text] [Related]

  • 39. Aberrant expression of the transcriptional factor Twist1 promotes invasiveness in ALK-positive anaplastic large cell lymphoma.
    Zhang J, Wang P, Wu F, Li M, Sharon D, Ingham RJ, Hitt M, McMullen TP, Lai R.
    Cell Signal; 2012 Apr 24; 24(4):852-8. PubMed ID: 22155737
    [Abstract] [Full Text] [Related]

  • 40. Anaplastic lymphoma kinase immunoreactivity correlates with ALK gene rearrangement and transcriptional up-regulation in non-small cell lung carcinomas.
    Boland JM, Erdogan S, Vasmatzis G, Yang P, Tillmans LS, Johnson MR, Wang X, Peterson LM, Halling KC, Oliveira AM, Aubry MC, Yi ES.
    Hum Pathol; 2009 Aug 24; 40(8):1152-8. PubMed ID: 19386350
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.